Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre J Marie

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Current Topics in Developmental Biology|March 24, 2019
Fibroblast growth factors in skeletal developmentDavid M Ornitz, Pierre J Marie
Genes & Development|June 25, 2002
FGF signaling pathways in endochondral and intramembranous bone development and human genetic diseaseDavid M Ornitz, Pierre J Marie
Genes & Development|July 30, 2015
Fibroblast growth factor signaling in skeletal development and diseaseDavid M Ornitz, Pierre J Marie
Plos One|December 17, 2009
N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signallingEric Haÿ, Alexandra Nouraud, Pierre J Marie
The Journal of Biological Chemistry|May 21, 2011
The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitinationNicolas Sévère, Hichem Miraoui, Pierre J Marie
Biochemical and Biophysical Research Communications|September 25, 2002
TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblastsMalika Yousfi, Françoise Lasmoles, Pierre J Marie
American Journal of Physiology. Endocrinology and Metabolism|April 2, 2008
Transforming growth factor-beta prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signalingCécilie Dufour, Xavier Holy, Pierre J Marie
The Journal of Biological Chemistry|September 2, 2008
Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasionOlivia Fromigué, Zahia Hamidouche, Pierre J Marie
Trends in Endocrinology and Metabolism: TEM|July 19, 2014
Integrin and cadherin signaling in bone: role and potential therapeutic targetsPierre J Marie, Eric Haÿ, Zuzana Saidak
Current Pharmaceutical Design|August 24, 2004
Growth factors and bone formation in osteoporosis: roles for fibroblast growth factor and transforming growth factor betaOlivia Fromigué, Dominique Modrowski, Pierre J Marie
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Current Topics in Developmental Biology|March 24, 2019
Fibroblast growth factors in skeletal developmentDavid M Ornitz, Pierre J Marie
Genes & Development|June 25, 2002
FGF signaling pathways in endochondral and intramembranous bone development and human genetic diseaseDavid M Ornitz, Pierre J Marie
Genes & Development|July 30, 2015
Fibroblast growth factor signaling in skeletal development and diseaseDavid M Ornitz, Pierre J Marie
Plos One|December 17, 2009
N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signallingEric Haÿ, Alexandra Nouraud, Pierre J Marie
The Journal of Biological Chemistry|May 21, 2011
The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitinationNicolas Sévère, Hichem Miraoui, Pierre J Marie
Biochemical and Biophysical Research Communications|September 25, 2002
TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblastsMalika Yousfi, Françoise Lasmoles, Pierre J Marie
American Journal of Physiology. Endocrinology and Metabolism|April 2, 2008
Transforming growth factor-beta prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signalingCécilie Dufour, Xavier Holy, Pierre J Marie
The Journal of Biological Chemistry|September 2, 2008
Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasionOlivia Fromigué, Zahia Hamidouche, Pierre J Marie
Trends in Endocrinology and Metabolism: TEM|July 19, 2014
Integrin and cadherin signaling in bone: role and potential therapeutic targetsPierre J Marie, Eric Haÿ, Zuzana Saidak
Current Pharmaceutical Design|August 24, 2004
Growth factors and bone formation in osteoporosis: roles for fibroblast growth factor and transforming growth factor betaOlivia Fromigué, Dominique Modrowski, Pierre J Marie
Pageof 9